Eales Disease is a rare idiopathic retinal vasculopathy that primarily affects young adults. It is characterized by inflammation, retinal hemorrhages, and the formation of abnormal blood vessels in the retina. The prevalence of Eales Disease varies geographically, with higher rates reported in India and other Asian countries. However, due to limited data and underdiagnosis, the exact prevalence is uncertain. Eales Disease predominantly affects males and is more common in individuals aged 20-30 years. Early detection and prompt treatment are crucial in managing this condition and preventing vision loss.
Eales Disease is a rare idiopathic inflammatory disorder that primarily affects the retina of young adults. It is characterized by inflammation, retinal hemorrhages, and the formation of abnormal blood vessels in the retina. The exact cause of Eales Disease is unknown, but it is believed to be multifactorial, involving genetic, immunological, and environmental factors.
Due to its rarity, the prevalence of Eales Disease varies across different populations. However, it is more commonly reported in certain regions, such as India, where the prevalence has been estimated to be around 1 in 2,000 to 4,000 individuals. In other parts of the world, the prevalence is generally lower.
Eales Disease typically affects young adults between the ages of 20 and 40, with a slight male predominance. The disease often presents with symptoms like floaters, blurred vision, and loss of vision in one or both eyes. Early diagnosis and prompt treatment are crucial to prevent complications and preserve vision.
While Eales Disease is considered rare, its impact on affected individuals can be significant. Awareness, early detection, and appropriate management are essential in minimizing the burden of this condition on patients' lives.